Log In Sign up
The largest database of trusted experimental protocols

Ab124827

Manufactured by Abcam
Visit Supplier
Sourced in United States

Ab124827 is a laboratory equipment product from Abcam. It serves the core function of [CORE FUNCTION]. No further details or interpretation about the intended use of this product are provided.

Automatically generated - may contain errors

Lab products found in correlation

Anti actin, by Merck Group (1 mentions) Anti nqo1, by Santa Cruz Biotechnology (1 mentions) Anti nrf2, by Santa Cruz Biotechnology (1 mentions) Anti brd4, by Fortis Life Sciences (1 mentions) Anti gclm, by Abcam (1 mentions) Anti atg3, by Santa Cruz Biotechnology (1 mentions) Anti lc3b, by Cell Signaling Technology (1 mentions) Anti gapdh, by Santa Cruz Biotechnology (1 mentions) Ab25117, by Abcam (1 mentions) Ripa lysis buffer, by Sangon (1 mentions)

2 protocols using ab124827

1

Autophagy and Oxidative Stress Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell lysis and western blot were performed as described previously (Huang M, Leukemia 2013). Antibodies used for Immunoblots: anti-LC3B ( #2775, Cell Signaling), anti-Keap1 (sc-365626, G-2, Santa Cruz Biotechnology), anti-Atg3 (sc-393660, A-3, Santa Cruz Biotechnology), anti-NQO1 (sc-393736, F-8, Santa Cruz Biotechnology), anti-GCLM (Ab124827, Abcam), anti-Bcl2 (sc-56015, 100/D5, Santa Cruz Biotechnology), anti- p62 (sc-25575, H-290, Santa Cruz Biotechnology), anti-actin (A5441, Sigma), and anti-Nrf2 (sc-13032, H-300, Santa Cruz Biotechnology), anti-Brd4 (A301-985A50, BETHYL Laboratories). Anti-CEBPβ (sc-7962, H-7, Santa Cruz Biotechnology).
Huang M., Zhu L., Garcia J.S., Li M.X., Gentles A.J, & Mitchell B.S. (2018). Brd4 regulates the expression of essential autophagy genes and Keap1 in AML cells. Oncotarget, 9(14), 11665-11676.
+ Open protocol
+ Expand
2

Western Blot Analysis of SDF-1 and CXCR4

Cited 1 time
Check if the same lab product or an alternative is used in the 5 most similar protocols
The proteins were extracted from heart samples using RIPA Lysis Buffer [Sangon Biotech (Shanghai), Co., Ltd.]. Western blotting was performed with anti-SDF-1 (ab25117, abcam), anti-CXCR4 (ab124827, abcam), and anti-GAPDH (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, United States) primary antibodies and with relevant secondary anti-bodies (Santa Cruz Biotechnology, Inc.) as described previously (Chen et al., 2015 (link)).
Chen J., Wei J., Huang Y., Ma Y., Ni J., Li M., Zhu Y., Gao X, & Fan G. (2018). Danhong Injection Enhances the Therapeutic Efficacy of Mesenchymal Stem Cells in Myocardial Infarction by Promoting Angiogenesis. Frontiers in Physiology, 9, 991.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!